ES2196150T3 - Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion. - Google Patents

Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.

Info

Publication number
ES2196150T3
ES2196150T3 ES96915808T ES96915808T ES2196150T3 ES 2196150 T3 ES2196150 T3 ES 2196150T3 ES 96915808 T ES96915808 T ES 96915808T ES 96915808 T ES96915808 T ES 96915808T ES 2196150 T3 ES2196150 T3 ES 2196150T3
Authority
ES
Spain
Prior art keywords
deployment
antibodies
induce
immunological tolerance
tolerance induction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96915808T
Other languages
English (en)
Inventor
Robert W Knowles
Druie E Cavender
Judith M Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of ES2196150T3 publication Critical patent/ES2196150T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)

Abstract

LA INVENCION PROPORCIONA UN METODO DE INDUCCION DE TOLERANCIA INMUNOLOGICA Y UN METODO DE PREVENCION DEL RECHAZO DE HETEROINJERTOS. EN AMBOS METODOS, SE ADMINISTRAN COMPOSICIONES DE ANTICUERPO ANTICD4 NO DEPLECIONANTE A UN PRIMATE. TAMBIEN SE PRESENTAN COMPOSICIONES DE ANTICUERPO NO DEPLECIONANTE Y MEDULA OSEA DE DONANTE.
ES96915808T 1995-05-18 1996-05-16 Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion. Expired - Lifetime ES2196150T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44373995A 1995-05-18 1995-05-18

Publications (1)

Publication Number Publication Date
ES2196150T3 true ES2196150T3 (es) 2003-12-16

Family

ID=23762005

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96915808T Expired - Lifetime ES2196150T3 (es) 1995-05-18 1996-05-16 Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.

Country Status (10)

Country Link
EP (2) EP1161955A3 (es)
JP (1) JPH11505251A (es)
AT (1) ATE238066T1 (es)
AU (1) AU715052B2 (es)
CA (1) CA2221350A1 (es)
DE (1) DE69627665T2 (es)
DK (1) DK0840618T3 (es)
ES (1) ES2196150T3 (es)
PT (1) PT840618E (es)
WO (1) WO1996036359A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037454A (en) * 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
EP0946727B1 (en) * 1996-11-27 2007-01-24 Genentech, Inc. Antibody mutants
EP1395284B1 (en) * 2001-06-14 2010-12-08 Isis Innovation Limited Non-depleting anti-CD4 antibody TRX1 and its uses
US7541443B2 (en) 2001-06-14 2009-06-02 Tolerrx, Inc. Anti-CD4 antibodies
EP1460088A1 (en) 2003-03-21 2004-09-22 Biotest AG Humanized anti-CD4 antibody with immunosuppressive properties
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
US20090143288A1 (en) 2007-03-13 2009-06-04 Roche Palo Alto Llc Peptide-complement conjugates
CL2008002092A1 (es) 2007-07-20 2009-05-29 Hoffmann La Roche Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
EP2260057B1 (en) 2008-03-13 2016-11-23 Biotest AG Anti-CD4 antibody dosage regimen for treating autoimmune disease
EP2265643B1 (en) 2008-03-13 2016-10-19 Biotest AG Dosing regimen for treating psoriasis and rheumatoid arthritis
RU2540013C2 (ru) 2008-03-13 2015-01-27 Биотест Аг Средство для лечения заболевания
AU2009282413B2 (en) 2008-08-11 2014-07-17 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease
EP2471543A1 (en) 2010-12-02 2012-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US20140088021A1 (en) 2011-05-27 2014-03-27 Nektar Therapeutics Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904481A (en) * 1985-04-17 1990-02-27 The Board Of Trustess Of Leland Stanford University Method of conferring immuno-tolerance to a specific antigen
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies
GB8912497D0 (en) * 1989-05-31 1989-07-19 Cobbold Stephen P Monoclonal antibodies
GB8928874D0 (en) * 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
GB9020282D0 (en) * 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation

Also Published As

Publication number Publication date
AU715052B2 (en) 2000-01-13
CA2221350A1 (en) 1996-11-21
EP1161955A2 (en) 2001-12-12
PT840618E (pt) 2003-08-29
DE69627665T2 (de) 2004-02-19
ATE238066T1 (de) 2003-05-15
WO1996036359A1 (en) 1996-11-21
AU5747996A (en) 1996-11-29
DE69627665D1 (de) 2003-05-28
EP0840618A1 (en) 1998-05-13
DK0840618T3 (da) 2003-08-11
EP1161955A3 (en) 2001-12-19
EP0840618B1 (en) 2003-04-23
JPH11505251A (ja) 1999-05-18

Similar Documents

Publication Publication Date Title
ES2196150T3 (es) Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.
GEP20105118B (en) Anti-vegf antibodies
AU5055593A (en) Antibodies specific for HIV
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
PT817847E (pt) Receptor de il-17
AR001811A1 (es) Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones
DE69839587D1 (de) Enterokokkus antigene und vakzine
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
MY104946A (en) Antigen antibody conjugate.
ES2093778T3 (es) Nuevos anticuerpos y metodos para su uso.
DK0722340T3 (da) Immunologisk toleranceinducerende middel
ATE137802T1 (de) Monoklonaler antikörper, der mit einer neuen hla- determinante auf mhc-klasse-i-moleküle reagiert, und verfahren zur aktivierung von lymphozyten
BR9809656A (pt) Composição imunopotencializante
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
ES2193240T3 (es) Metodo y composicion para reconformar antigenos multi-epitopicos para iniciar una respuesta inmune.
ES2114064T3 (es) Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
BG103416A (en) Soluble lymphotoxin-beta receptors, antilymphotosoluble lymphotoxin- receptors, antilymphotoxin receptor antibodies and antilymphotoxin ligand antixin receptor antibodies and antilymphotoxin ligandbodies as therapeutical forms for the treatment of antibodies as therapeutical forms for the treatment of immunological diseases immunological diseases
GR3029483T3 (en) Antibodies against t-cells as therapeutics
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
PL288597A1 (en) Method of obtaining a pharmaceutic
ATE317269T1 (de) Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs)
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
HU9300349D0 (en) Method for producing dibenzo- or benzo-pyrido-cyclohepta-piperidine derivatives or piperidylidene or piperazine derivatives thereof as well as pharmaceutical preparatives contqining them
ES2051870T3 (es) Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t.
GB9510753D0 (en) Method for the molecular cloning of antigens,which are recognised by cd4+lymphocytes